Nerve health in people receiving cisplatin chemotherapy
Part of Brain & nervous system clinical trials.
This study looks at how cisplatin affects nerve activity in the arms and legs. It is for people about to start cisplatin, or those who have had nerve symptoms for at least 3 months after finishing cisplatin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You will start cisplatin chemotherapy, or you have nerve pain/numbness/tingling from past cisplatin that still bothers you 3 months after your last dose
- You do not have nerve problems from another cause before starting cisplatin
- You are not taking another chemotherapy drug that can also cause nerve damage
- You do not have a pacemaker or other electrical device in your chest or spine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
This study looks for small molecules in the blood that might predict nerve damage caused by certain chemotherapies. If you have colorectal or lung cancer and are starting a specific chemo plan, this trial could help researchers understand why some people get nerve problems and others don't.
This study looks at how chemotherapy-related nerve damage affects daily activities like walking and standing. It includes people who currently have or have had nerve-damaging chemotherapy and are experiencing nerve pain or weakness.
This study looks at tiny particles in your blood to understand and potentially predict nerve damage caused by certain chemotherapy drugs. Researchers will monitor you before, during, and after your cancer treatment to see if these particles can help warn doctors about this common side effect.
This study looks at how cisplatin chemotherapy affects the kidneys. It may help doctors better predict and protect against kidney damage when patients start cisplatin.
Hear when a new Peripheral Neuropathy Due to Chemotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.